Severity of bronchiolitis in infants is associated with their parents' tobacco habit

Diego Rodríguez-Álvarez1, Cristina Rodríguez-De Tembleque1, Emilio Cendejas-Bueno2

  • 1Paediatric Intensive Care Unit, Children's University Hospital La Paz, Madrid, Spain.

Insights

Secondhand smoke exposure significantly increases the risk of invasive mechanical ventilation and pulmonary bacterial superinfections in infants with severe acute bronchiolitis. This highlights a critical risk factor for pediatric intensive care admissions.

Area of Science:

  • Pediatric Intensive Care Medicine
  • Epidemiology
  • Environmental Health

Background:

  • Environmental tobacco smoke is a known risk factor for pediatric lower respiratory tract infections.
  • Tobacco smoke alters respiratory tract structure and impairs immune response in children.

Purpose of the Study:

  • To investigate the impact of tobacco smoke exposure on outcomes in pediatric intensive care unit (PICU) patients with severe acute bronchiolitis.
  • To determine the association between secondhand smoke exposure and the need for invasive mechanical ventilation and pulmonary bacterial superinfections.

Main Methods:

  • A prospective epidemiological observational study involving 102 infants under 2 years old admitted to the PICU with bronchiolitis.
  • Data collected included parental smoking status and, for ventilated patients, endotracheal aspirate analysis.
  • Statistical analysis compared outcomes between infants exposed and unexposed to secondhand smoke.

Main Results:

  • Infants with parents who smoked were significantly more likely to require invasive mechanical ventilation (47% vs. 19%, p = 0.007).
  • Among ventilated infants, those with secondhand smoke exposure had a higher incidence of pulmonary bacterial superinfection (71% vs. 21%, p = 0.012).
  • Secondhand smoke exposure was linked to increased need and duration of mechanical ventilation and longer PICU stays.

Conclusions:

  • Secondhand smoke exposure is a significant risk factor for severe acute bronchiolitis in infants.
  • Exposure increases the likelihood of requiring invasive mechanical ventilation and developing pulmonary bacterial superinfections.
  • This underscores the importance of smoke-free environments for vulnerable pediatric populations.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.9K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.2K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
618
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.2K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
447
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.8K